c-Met Monoclonal Antibody (3D4) (18-7366)
![Recombinant Anti-Met (c-Met) antibody [SP44] - C-terminal KO Tested (ab227637)](https://www.abcam.com/ps/products/227/ab227637/Images/ab227637-4-AntiMet-cMet-antibody-SP44--Cterminal-IHC-Human-colon-carcinoma.jpg "Recombinant Anti-Met (c-Met) antibody [SP44] - C-terminal KO Tested (ab227637)")
Recombinant Anti-Met (c-Met) antibody [SP44] - C-terminal KO Tested (ab227637)
c-Met (Cytoplasmic) antibody (25869-1-AP) | Proteintech
Progress and challenge in development of biotherapeutics targeting MET receptor for treatment of advanced cancer - ScienceDirect
Amivantamab (JNJ-61186372) is a Human EGFR-MET Bispecific Antibody - Network of Cancer Research
Anti-c-Met antibody
MM-131, a bispecific anti-Met/EpCAM mAb, inhibits HGF-dependent and HGF-independent Met signaling through concurrent binding to EpCAM | PNAS
Anti-c-Met monoclonal antibody ABT-700 breaks oncogene addiction in tumors with MET amplification | BMC Cancer | Full Text
Induction of MET Receptor Tyrosine Kinase Down-regulation through Antibody-mediated Receptor Clustering | Scientific Reports
Met (c Met) Polyclonal Antibody – Bioss
Targeting MET in Lung Cancer: Will Expectations Finally Be MET? - ScienceDirect
![Recombinant Anti-Met (c-Met) antibody [EP1454Y] - N-terminal KO Tested (ab51067)](https://www.abcam.com/ps/products/51/ab51067/Images/ab51067-481633-ab51067-anticmet-hela-002.jpg "Recombinant Anti-Met (c-Met) antibody [EP1454Y] - N-terminal KO Tested (ab51067)")
Recombinant Anti-Met (c-Met) antibody [EP1454Y] - N-terminal KO Tested (ab51067)
7 Inhibition of MET signaling in cancer therapies. Anti-HGF monoclonal... | Download Scientific Diagram
![Recombinant Anti-Met (c-Met) antibody [EP1454Y] - N-terminal KO Tested (ab51067)](https://www.abcam.com/ps/products/51/ab51067/Images/ab51067-254008-anti-met-c-met-antibody-ep1454y-n-terminal-immunohistochemistry.jpg "Recombinant Anti-Met (c-Met) antibody [EP1454Y] - N-terminal KO Tested (ab51067)")
Recombinant Anti-Met (c-Met) antibody [EP1454Y] - N-terminal KO Tested (ab51067)
![Recombinant Anti-Met (c-Met) antibody [SP44] - C-terminal KO Tested (ab227637)](https://www.abcam.com/ps/products/227/ab227637/Images/ab227637-290322-anti-met-c-met-antibody-sp44-c-terminal-immunohistochemistry.jpg "Recombinant Anti-Met (c-Met) antibody [SP44] - C-terminal KO Tested (ab227637)")
Recombinant Anti-Met (c-Met) antibody [SP44] - C-terminal KO Tested (ab227637)
![Recombinant Anti-Met (c-Met) antibody [EPR19067] KO Tested (ab216574) | Abcam](https://www.abcam.com/ps/products/216/ab216574/Images/ab216574-480637-antimet-cmet-antibody-ep1454y--nterminal-western-blot.JPG "Recombinant Anti-Met (c-Met) antibody [EPR19067] KO Tested (ab216574) | Abcam")
Recombinant Anti-Met (c-Met) antibody [EPR19067] KO Tested (ab216574) | Abcam
Frontiers | The MET Oncogene as a Therapeutical Target in Cancer Invasive Growth
They Should Be in Jail': Nan Goldin, Anti-Sackler Opioid Activists Take Fight to Guggenheim, Met – ARTnews.com
Frontiers | The Emerging Role of the c-MET-HGF Axis in Non-small Cell Lung Cancer Tumor Immunology and Immunotherapy
The c-MET oncoprotein: Function, mechanisms of degradation and its targeting by novel anti-cancer agents - ScienceDirect
JPM | Free Full-Text | MET Gene Dysregulation as a Promising Therapeutic Target in Lung Cancer—A Review
Anti-MET Antibody (PACO01060) | WB
IJMS | Free Full-Text | Tumor Inhibitory Effect of IRCR201, a Novel Cross-Reactive c-Met Antibody Targeting the PSI Domain
MET is required for the recruitment of anti-tumoural neutrophils | Nature
InlB-Dependent Internalization of Listeria Is Mediated by the Met Receptor Tyrosine Kinase: Cell
